| n | PC |
---|
n | % | Previous study |
---|
CPa | 204b | 123 | 60.8 | 68% [4] |
SPT | 223 | 15 | 6.7 | 30% [3] |
SCN | 381 | 12 | 3.1 | 30% [3] |
P-NN | 345 | 10 | 2.9 | 20–22% [3] |
IPMNc | 363 | 5 | 1.4 | 20–80% [3] |
MCN | 187 | 3 | 1.6 | 15% [3] |
 | 3755 | 168 | 4.5 | – |
- a Including the 34 patients with CP and PDAC (Calcification, n = 25; no Calcification, n = 9) and the two patients with IPMN combined with calcification
- bThere were 41 cases (43.6%) with PC and 29 cases (30.9%) with PDAC in cases with a pancreatic mass (n = 94), and 82 cases (74.5%) with PC and 5 cases (4.5%) with PDAC in cases without pancreatic mass (n = 110)
- cNot included two patients with CP combined IPMN, and 4 out of 5 cases were malignant. CP chronic pancreatitis, IPMN intraductal papillary mucinous neoplasm, PDAC pancreatic ductal adenocarcinoma, SPT solid pseudopapillary tumours, SCN serous cystic neoplasm, P-NN: pancreatic neuroendocrine neoplasm, MCN mucinous cystic neoplasm